141 related articles for article (PubMed ID: 35509688)
1. Smurf2 suppresses the metastasis of hepatocellular carcinoma via ubiquitin degradation of Smad2.
Song D; Li S; Ning L; Zhang S; Cai Y
Open Med (Wars); 2022; 17(1):384-396. PubMed ID: 35509688
[TBL] [Abstract][Full Text] [Related]
2. TTC3 contributes to TGF-β
Kim JH; Ham S; Lee Y; Suh GY; Lee YS
Cell Death Dis; 2019 Jan; 10(2):92. PubMed ID: 30696809
[TBL] [Abstract][Full Text] [Related]
3. SMURF2 facilitates ubiquitin-mediated degradation of ID2 to attenuate lung cancer cell proliferation.
Han M; Guo Y; Li Y; Zeng Q; Zhu W; Jiang J
Int J Biol Sci; 2023; 19(11):3324-3340. PubMed ID: 37497010
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression.
David D; Surendran A; Thulaseedharan JV; Nair AS
BMC Cancer; 2018 Mar; 18(1):284. PubMed ID: 29534682
[TBL] [Abstract][Full Text] [Related]
5. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling.
Lin X; Liang M; Feng XH
J Biol Chem; 2000 Nov; 275(47):36818-22. PubMed ID: 11016919
[TBL] [Abstract][Full Text] [Related]
6. High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
Fukuchi M; Fukai Y; Masuda N; Miyazaki T; Nakajima M; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
Cancer Res; 2002 Dec; 62(24):7162-5. PubMed ID: 12499250
[TBL] [Abstract][Full Text] [Related]
7. Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradation.
Hsu HY; Lin TY; Wu YC; Tsao SM; Hwang PA; Shih YW; Hsu J
Oncotarget; 2014 Sep; 5(17):7870-85. PubMed ID: 25149540
[TBL] [Abstract][Full Text] [Related]
8. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
9. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
[TBL] [Abstract][Full Text] [Related]
10. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis.
Ji F; Zhou M; Sun Z; Jiang Z; Zhu H; Xie Z; Ouyang X; Zhang L; Li L
Cancer Commun (Lond); 2021 Oct; 41(10):1007-1023. PubMed ID: 34196494
[TBL] [Abstract][Full Text] [Related]
11. SMURF2 and SMAD7 induce SARA degradation via the proteasome.
Wojtowicz S; Lee S; Chan E; Ng E; Campbell CI; Di Guglielmo GM
Cell Signal; 2020 Aug; 72():109627. PubMed ID: 32283253
[TBL] [Abstract][Full Text] [Related]
12. The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells.
Dong S; Liu J; Li L; Wang H; Ma H; Zhao Y; Zhao J
Am J Physiol Cell Physiol; 2019 May; 316(5):C632-C640. PubMed ID: 30758996
[TBL] [Abstract][Full Text] [Related]
13. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation.
Li Y; Yang D; Tian N; Zhang P; Zhu Y; Meng J; Feng M; Lu Y; Liu Q; Tong L; Hu L; Zhang L; Yang JY; Wu L; Tong X
J Biol Chem; 2019 Oct; 294(40):14745-14756. PubMed ID: 31409643
[TBL] [Abstract][Full Text] [Related]
15. S100A6 promotes proliferation and migration of HepG2 cells via increased ubiquitin-dependent degradation of p53.
Song D; Xu B; Shi D; Li S; Cai Y
Open Med (Wars); 2020; 15(1):317-326. PubMed ID: 33335992
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of Smurf2 during the process of rat liver fibrosis.
Cai Y; Shen XZ; Zhou CH; Wang JY
Chin J Dig Dis; 2006; 7(4):237-45. PubMed ID: 17054587
[TBL] [Abstract][Full Text] [Related]
17. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
